Meredith C Meacham1,2,3, Steffanie A Strathdee1, Gudelia Rangel4, Richard F Armenta1,2,5, Tommi L Gaines1, Richard S Garfein1. 1. Division of Global Public Health, Department of Medicine, University of California, San Diego, La Jolla, California. 2. Graduate School of Public Health, San Diego State University, San Diego, California. 3. Department of Psychiatry, University of California San Francisco, San Francisco, California. 4. U.S.-Mexico Border Health Commission, Mexico Section, Tijuana, Baja California, Mexico. 5. Division of Epidemiology, Department of Family Medicine and Public Health, University of California, San Diego, La Jolla, California.
Abstract
OBJECTIVE: Although persons who inject drugs (PWID) in the western United States-Mexico border region are known to inject both heroin and methamphetamine, little is known about the prevalence and risks associated with co-injection of this depressant-stimulant combination (also known as "goofball" and "Mexican speedball"). METHOD: Baseline data from parallel cohort studies of PWID conducted concurrently in San Diego, CA, and Tijuana, Mexico, were used to estimate the prevalence and identify correlates of heroin-methamphetamine co-injection. PWID older than 18 years of age who reported injecting illicit drugs in the past month (N = 1,311; 32.7% female) were recruited in San Diego (n = 576) and Tijuana (n = 735) and completed interviewer-administered questionnaires. Bivariate and multivariable logistic regression analyses were used to identify correlates of heroin-meth-amphetamine co-injection. RESULTS: The prevalence of co-injection in the past 6 months was 39.9% overall and was higher in Tijuana (55.8%) than in San Diego (19.8%). In multivariable analyses adjusting for study cohort, distributive syringe sharing, purchasing syringes prefilled with drugs, finding it hard to get new syringes, reporting great or urgent need for treatment, and younger age were independently associated with co-injection. Past-6-month overdose was significantly associated with higher odds of co-injection in San Diego than in Tijuana. CONCLUSIONS: These findings indicate that heroin-methamphetamine co-injection is more common in Tijuana than in San Diego, yet this practice was only associated with overdose in San Diego. Heroin-methamphetamine coinjection was also independently associated with HIV-associated injection risk behaviors. Overdose-prevention interventions should address co-injection of depressants and stimulants.
OBJECTIVE: Although persons who inject drugs (PWID) in the western United States-Mexico border region are known to inject both heroin and methamphetamine, little is known about the prevalence and risks associated with co-injection of this depressant-stimulant combination (also known as "goofball" and "Mexican speedball"). METHOD: Baseline data from parallel cohort studies of PWID conducted concurrently in San Diego, CA, and Tijuana, Mexico, were used to estimate the prevalence and identify correlates of heroin-methamphetamine co-injection. PWID older than 18 years of age who reported injecting illicit drugs in the past month (N = 1,311; 32.7% female) were recruited in San Diego (n = 576) and Tijuana (n = 735) and completed interviewer-administered questionnaires. Bivariate and multivariable logistic regression analyses were used to identify correlates of heroin-meth-amphetamine co-injection. RESULTS: The prevalence of co-injection in the past 6 months was 39.9% overall and was higher in Tijuana (55.8%) than in San Diego (19.8%). In multivariable analyses adjusting for study cohort, distributive syringe sharing, purchasing syringes prefilled with drugs, finding it hard to get new syringes, reporting great or urgent need for treatment, and younger age were independently associated with co-injection. Past-6-month overdose was significantly associated with higher odds of co-injection in San Diego than in Tijuana. CONCLUSIONS: These findings indicate that heroin-methamphetamine co-injection is more common in Tijuana than in San Diego, yet this practice was only associated with overdose in San Diego. Heroin-methamphetamine coinjection was also independently associated with HIV-associated injection risk behaviors. Overdose-prevention interventions should address co-injection of depressants and stimulants.
Authors: Jesus Bucardo; Kimberly C Brouwer; Carlos Magis-Rodríguez; Rebeca Ramos; Miguel Fraga; Saida G Perez; Thomas L Patterson; Steffanie A Strathdee Journal: Drug Alcohol Depend Date: 2005-04-01 Impact factor: 4.492
Authors: Kristen C Ochoa; Peter J Davidson; Jennifer L Evans; Judith A Hahn; Kimberly Page-Shafer; Andrew R Moss Journal: Drug Alcohol Depend Date: 2005-06-14 Impact factor: 4.492
Authors: Alexis M Roth; Richard A Armenta; Karla D Wagner; Scott C Roesch; Ricky N Bluthenthal; Jazmine Cuevas-Mota; Richard S Garfein Journal: Subst Use Misuse Date: 2014-10-14 Impact factor: 2.164
Authors: Louisa Degenhardt; Bradley Mathers; Mauro Guarinieri; Samiran Panda; Benjamin Phillips; Steffanie A Strathdee; Mark Tyndall; Lucas Wiessing; Alex Wodak; John Howard Journal: Int J Drug Policy Date: 2010-02-01
Authors: Thomas Kerr; Nadia Fairbairn; Mark Tyndall; David Marsh; Kathy Li; Julio Montaner; Evan Wood Journal: Drug Alcohol Depend Date: 2006-09-07 Impact factor: 4.492
Authors: Richard S Garfein; Amanda Rondinelli; Richard F W Barnes; Jazmine Cuevas; Mitcheal Metzner; Michele Velasquez; David Rodriguez; Meredith Reilly; Jian Xing; Eyasu H Teshale Journal: J Urban Health Date: 2013-06 Impact factor: 3.671
Authors: Richard S Garfein; Edgar R Monterroso; Tony C Tong; David Vlahov; Don C Des Jarlais; Peter Selwyn; Peter R Kerndt; Carl Word; M Daniel Fernando; Lawrence J Ouellet; Scott D Holmberg Journal: J Urban Health Date: 2004-06 Impact factor: 3.671
Authors: Sara Nelson Glick; Richard Burt; Kim Kummer; Joe Tinsley; Caleb J Banta-Green; Matthew R Golden Journal: Drug Alcohol Depend Date: 2017-11-16 Impact factor: 4.492
Authors: Claudia Rafful; Jason Melo; María Elena Medina-Mora; Gudelia Rangel; Xiaoying Sun; Sonia Jain; Dan Werb Journal: Drug Alcohol Rev Date: 2017-11-22
Authors: Danielle Horyniak; Steffanie A Strathdee; Brooke S West; Meredith Meacham; Gudelia Rangel; Tommi L Gaines Journal: Drug Alcohol Depend Date: 2018-02-21 Impact factor: 4.492
Authors: Andrea M Lopez; Zena Dhatt; Mary Howe; Marwa Al-Nassir; Amy Billing; Eleanor Artigiani; Eric D Wish Journal: Int J Drug Policy Date: 2021-01-19
Authors: Kanna Hayashi; Evan Wood; Huiru Dong; Jane A Buxton; Nadia Fairbairn; Kora DeBeck; M-J Milloy; Thomas Kerr Journal: Drug Alcohol Rev Date: 2021-02-18